Volitionrx Stock Performance
| VNRX Stock | USD 0.79 0.02 1.99% |
On a scale of 0 to 100, Volitionrx holds a performance score of 6. The entity has a beta of 0.94, which indicates possible diversification benefits within a given portfolio. Volitionrx returns are very sensitive to returns on the market. As the market goes up or down, Volitionrx is expected to follow. Please check Volitionrx's semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Volitionrx's existing price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Volitionrx are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Volitionrx showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | VNRX Nu.Q Vet Test is now available in 17 countries. Cost cutting continues in a plan to be cash flow neutral in 2025. Management focused on signing licensing d... | 08/29/2024 |
2 | Acquisition by Kway Jasmine of 16750 shares of Volitionrx subject to Rule 16b-3 | 08/30/2024 |
3 | Acquisition by Forterre Gael of 10240 shares of Volitionrx subject to Rule 16b-3 | 09/04/2024 |
4 | Acquisition by Innes Guy Archibald of 400000 shares of Volitionrx subject to Rule 16b-3 | 09/16/2024 |
5 | VolitionRx announces executive employment updates - Investing.com | 09/27/2024 |
6 | Insider Trading | 09/30/2024 |
7 | Disposition of 5200 shares by Jacob Micallef of Volitionrx at 0.883 subject to Rule 16b-3 | 10/04/2024 |
8 | Ground Swell Capital LLC Grows Stock Holdings in VolitionRx Limited | 11/04/2024 |
9 | StockNews.com Begins Coverage on VolitionRx - MarketBeat | 11/11/2024 |
10 | VolitionRX Ltd Reports Q3 Revenue of 475,000, Missing Estimates of 0.65 Million | 11/14/2024 |
| Begin Period Cash Flow | 10.9 M |
Volitionrx |
Volitionrx Relative Risk vs. Return Landscape
If you would invest 64.00 in Volitionrx on August 24, 2024 and sell it today you would earn a total of 15.00 from holding Volitionrx or generate 23.44% return on investment over 90 days. Volitionrx is currently generating 0.4957% in daily expected returns and assumes 5.8891% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Volitionrx, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Volitionrx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Volitionrx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Volitionrx, and traders can use it to determine the average amount a Volitionrx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0842
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VNRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.89 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.5 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Volitionrx is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Volitionrx by adding it to a well-diversified portfolio.
Volitionrx Fundamentals Growth
Volitionrx Stock prices reflect investors' perceptions of the future prospects and financial health of Volitionrx, and Volitionrx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Volitionrx Stock performance.
| Return On Equity | -7.3 | ||||
| Return On Asset | -1.01 | ||||
| Operating Margin | (17.66) % | ||||
| Current Valuation | 75.53 M | ||||
| Shares Outstanding | 92.66 M | ||||
| Price To Earning | (4.52) X | ||||
| Price To Book | 38.44 X | ||||
| Price To Sales | 76.96 X | ||||
| Revenue | 775.3 K | ||||
| Gross Profit | 306.39 K | ||||
| EBITDA | (34.04 M) | ||||
| Net Income | (35.32 M) | ||||
| Cash And Equivalents | 16.42 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 5.86 M | ||||
| Debt To Equity | 1.57 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | (0.1) X | ||||
| Cash Flow From Operations | (18.06 M) | ||||
| Earnings Per Share | (0.36) X | ||||
| Market Capitalization | 75.15 M | ||||
| Total Asset | 27.95 M | ||||
| Retained Earnings | (202.58 M) | ||||
| Working Capital | (9.98 M) | ||||
| Current Asset | 6.22 M | ||||
| Current Liabilities | 1.12 M | ||||
About Volitionrx Performance
Evaluating Volitionrx's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Volitionrx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Volitionrx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 216.97 | 192.86 | |
| Return On Tangible Assets | (1.26) | (1.33) | |
| Return On Capital Employed | 9.26 | 9.72 | |
| Return On Assets | (1.26) | (1.33) | |
| Return On Equity | 4.53 | 4.75 |
Things to note about Volitionrx performance evaluation
Checking the ongoing alerts about Volitionrx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Volitionrx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Volitionrx had very high historical volatility over the last 90 days | |
| Volitionrx has some characteristics of a very speculative penny stock | |
| Volitionrx has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 775.3 K. Net Loss for the year was (35.32 M) with profit before overhead, payroll, taxes, and interest of 306.39 K. | |
| Volitionrx currently holds about 16.42 M in cash with (18.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
| Roughly 23.0% of the company outstanding shares are owned by insiders | |
| Latest headline from gurufocus.com: VolitionRX Ltd Reports Q3 Revenue of 475,000, Missing Estimates of 0.65 Million |
- Analyzing Volitionrx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Volitionrx's stock is overvalued or undervalued compared to its peers.
- Examining Volitionrx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Volitionrx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Volitionrx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Volitionrx's stock. These opinions can provide insight into Volitionrx's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.